763 related articles for article (PubMed ID: 10728802)
1. Complications of cirrhosis. II. Renal and circulatory dysfunction. Lights and shadows in an important clinical problem.
Arroyo V; Jiménez W
J Hepatol; 2000; 32(1 Suppl):157-70. PubMed ID: 10728802
[TBL] [Abstract][Full Text] [Related]
2. Management of ascites and hepatorenal syndrome.
Piano S; Tonon M; Angeli P
Hepatol Int; 2018 Feb; 12(Suppl 1):122-134. PubMed ID: 28836115
[TBL] [Abstract][Full Text] [Related]
3. Fluid retention in cirrhosis: pathophysiology and management.
Kashani A; Landaverde C; Medici V; Rossaro L
QJM; 2008 Feb; 101(2):71-85. PubMed ID: 18184668
[TBL] [Abstract][Full Text] [Related]
4. [Treatment of ascites, hyponatremia and hepatorenal syndrome in liver cirrhosis].
Ackermann D
Ther Umsch; 2009 Nov; 66(11):747-51. PubMed ID: 19885792
[TBL] [Abstract][Full Text] [Related]
5. Clinical Implications, Evaluation, and Management of Hyponatremia in Cirrhosis.
Praharaj DL; Anand AC
J Clin Exp Hepatol; 2022; 12(2):575-594. PubMed ID: 35535075
[TBL] [Abstract][Full Text] [Related]
6. Pathogenetic factors and clinical elements in ascites and hepatorenal syndrome during liver cirrhosis.
Gentilini P; Laffi G; La Villa G; Raggi VC
Ann Ital Med Int; 1999; 14(4):264-84. PubMed ID: 10638019
[TBL] [Abstract][Full Text] [Related]
7. Pathophysiology, diagnosis and clinical management of hepatorenal syndrome: from classic to new drugs.
Barbano B; Sardo L; Gigante A; Gasperini ML; Liberatori M; Giraldi GD; Lacanna A; Amoroso A; Cianci R
Curr Vasc Pharmacol; 2014 Jan; 12(1):125-35. PubMed ID: 24678726
[TBL] [Abstract][Full Text] [Related]
8. Ascites and hepatorenal syndrome: pathogenesis and treatment strategies.
Ginès P; Arroyo V; Rodés J
Adv Intern Med; 1998; 43():99-142. PubMed ID: 9506180
[No Abstract] [Full Text] [Related]
9. LEFT ventricular function assessed by echocardiography in cirrhosis: relationship to systemic hemodynamics and renal dysfunction.
Nazar A; Guevara M; Sitges M; Terra C; Solà E; Guigou C; Arroyo V; Ginès P
J Hepatol; 2013 Jan; 58(1):51-7. PubMed ID: 22989573
[TBL] [Abstract][Full Text] [Related]
10. Hyponatremia in cirrhosis: pathophysiology and management.
John S; Thuluvath PJ
World J Gastroenterol; 2015 Mar; 21(11):3197-205. PubMed ID: 25805925
[TBL] [Abstract][Full Text] [Related]
11. Update on peripheral arterial vasodilation, ascites and hepatorenal syndrome in cirrhosis.
Knotek M; Rogachev B; Schrier RW
Can J Gastroenterol; 2000 Nov; 14 Suppl D():112D-121D. PubMed ID: 11110623
[TBL] [Abstract][Full Text] [Related]
12. Hyponatremia in Cirrhosis: An Update.
Alukal JJ; John S; Thuluvath PJ
Am J Gastroenterol; 2020 Nov; 115(11):1775-1785. PubMed ID: 33156095
[TBL] [Abstract][Full Text] [Related]
13. Management of ascites in patients with liver cirrhosis: recent evidence and controversies.
Hsu SJ; Huang HC
J Chin Med Assoc; 2013 Mar; 76(3):123-30. PubMed ID: 23497963
[TBL] [Abstract][Full Text] [Related]
14. Pathophysiology of Hepatorenal Syndrome.
Velez JCQ; Latt N; Rodby RA
Adv Kidney Dis Health; 2024 Mar; 31(2):87-99. PubMed ID: 38649221
[TBL] [Abstract][Full Text] [Related]
15. Challenges and Management of Liver Cirrhosis: Pathophysiology of Renal Dysfunction in Cirrhosis.
Solà E; Ginès P
Dig Dis; 2015; 33(4):534-8. PubMed ID: 26159270
[TBL] [Abstract][Full Text] [Related]
16. Hepatorenal syndrome.
Gattoni A; Marotta F; Vangieri B; Pisani G; Cristiano F
Clin Ter; 2004 Sep; 155(9):375-89. PubMed ID: 15700631
[TBL] [Abstract][Full Text] [Related]
17. Renal function abnormalities, prostaglandins, and effects of nonsteroidal anti-inflammatory drugs in cirrhosis with ascites. An overview with emphasis on pathogenesis.
Arroyo V; Ginés P; Rimola A; Gaya J
Am J Med; 1986 Aug; 81(2B):104-22. PubMed ID: 2944381
[TBL] [Abstract][Full Text] [Related]
18. Chinese guidelines on the management of ascites and its related complications in cirrhosis.
; Xu X; Duan Z; Ding H; Li W; Jia J; Wei L; Linghu E; Zhuang H
Hepatol Int; 2019 Jan; 13(1):1-21. PubMed ID: 30656520
[TBL] [Abstract][Full Text] [Related]
19. Review article: pathogenesis and pathophysiology of hepatorenal syndrome--is there scope for prevention?
Møller S; Henriksen JH
Aliment Pharmacol Ther; 2004 Sep; 20 Suppl 3():31-41; discussion 42-3. PubMed ID: 15335398
[TBL] [Abstract][Full Text] [Related]
20. Pathophysiology, diagnosis and treatment of ascites in cirrhosis.
Arroyo V
Ann Hepatol; 2002; 1(2):72-9. PubMed ID: 15115971
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
